Quillivant XR
NDC 24478-321, methylphenidate hydrochloride, suspension, extended release, from NextWave Pharmaceuticals, Inc.
- Product NDC
- 24478-321
- Status
- Listed
- Labeler
- NextWave Pharmaceuticals, Inc
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202100
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/24478-321 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE300 mg/60mL
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24478-321-02 | 24478032102 | 1 BOTTLE in 1 CARTON (24478-321-02) / 60 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c2dc2109-44a6-4797-b04e-18761dd9d45aNADAC price for package 24478032102
GET /v1/drugs/nadac/24478032102
Use it
Look up 24478-321 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24478-321 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24478-321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.